Tobacco
17
4
6
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
5.9%
1 terminated out of 17 trials
75.0%
-11.5% vs benchmark
18%
3 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (17)
Secondhand Smoke Respiratory Health Study
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers
Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Targeting Lifestyle to Improve Colorectal Cancer Screening
Understanding Vape Marketing Study
Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells
Epidemiological Study to Assess the Prevalence of Lung Cancer
Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence
Message Testing for Tobacco-Related Corrective Statements
Education Against Tobacco Randomized Trial
Education Against Tobacco Randomized Trial in Bosnia and Herzegovina
Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels and Smoking Behavior Among Early Adolescents in Jordan